TAGLN co‐distributed with GSC markers CD133, CD15, SOX2, and OLIG2 in glioma cells (Figure 2E; Figure S2G, Supporting Information), suggesting that TAGLN was preferentially expressed in GSCs in patient tissues. This evidence concerns the gene TAGLN and glioma.